Advanced Search

 

Study ID Status Title Patient Level Data
109059 Completed A Phase II Study to Evaluate: Delay in Intravaginal Ejaculatory Latency Time (IELT), Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Two Oral Doses of GSK557296 in a Randomized, Double Blind, Placebo-Controlled, Parallel Group Study in Men with Premature Ejaculation Study Listed on ClinicalStudyDataRequest.com
109063 Relinquished Non-inferiority of GSK Biologicals’ meningococcal vaccine 134612 given concomitantly with GSK Biologicals’ Twinrix™ versus 134612 alone and Twinrix™ alone in healthy subjects aged 11 through 17 years. Study Listed on ClinicalStudyDataRequest.com
109067 Relinquished Lot-to-Lot Consistency, Non-Inferiority Versus Mencevax™ and Evaluation of the co-Administration With Fluarix™ of GSK Biologicals' Meningococcal Vaccine GSK134612, in Healthy Subjects Aged 18 Through 55 Years of Age Study Listed on ClinicalStudyDataRequest.com
109069 Relinquished Primary vaccination study in subjects aged 11-17 years to demonstrate the non-inferiority of GSK Biologicals' Meningococcal vaccine GSK134612 vaccine versus Mencevax™ ACWY Study Listed on ClinicalStudyDataRequest.com
109179 Completed Immunogenicity and safety study of GlaxoSmithKline Biologicals' HPV vaccine GSK580299 administered according to an alternative dosing schedule as compared to the standard dosing schedule in young female subjects aged 15-25 years Study Listed on ClinicalStudyDataRequest.com
109216 Completed Immunogenicity and safety of two doses of GlaxoSmithKline (GSK) Biologicals’ oral live attenuated human rotavirus (HRV) liquid vaccine (GSK 357941A) in healthy infants. Study Listed on ClinicalStudyDataRequest.com
109275 Completed An Open-Label, Single Sequence Study to Examine the Effects of Esomeprazole on the Pharmacokinetics of Orally Administered Lapatinib in Subjects with Metastatic ErbB2 Positive Breast Cancer
109326 Completed Veramyst vs. other Rx's in managed care
109375 Relinquished Study to assess immunogenicity, reactogenicity and safety of primary vaccination with GSK Biologicals' MenACWY vaccine (GSK134612) given as 1 or 2 doses to healthy toddlers 9-12 months of age Study Listed on ClinicalStudyDataRequest.com
109377 Relinquished Study to Assess Immunogenicity, Reactogenicity and Safety of 1 Dose of GSK Biologicals' Meningococcal Vaccine GSK134612 vs. 1 Dose of Sanofi-Pasteur's Menactra® in Healthy Subjects 10-25 Years. Study Listed on ClinicalStudyDataRequest.com
109385 Completed A randomized, open label, 4 period crossover study in healthy subjects to determine the effect of particle size on the pharmacokinetics of a single mg dose of GW856553
109495 Relinquished Non-inferiority of GSK Biologicals' Meningococcal vaccine GSK134612 versus Mencevax™ in healthy subjects aged 2 through 10 years of age Study Listed on ClinicalStudyDataRequest.com
109507 Completed Booster Vaccination With Pneumococcal Vaccine GSK1024850A, a DTPa-Combined and MenC or Hib-MenC Vaccines Study Listed on ClinicalStudyDataRequest.com
109507 Completed Booster Vaccination With Pneumococcal Vaccine GSK1024850A, a DTPa-Combined and MenC or Hib-MenC Vaccines Study Listed on ClinicalStudyDataRequest.com
109509 Completed Booster vaccination course with the pneumococcal vaccine GSK 1024850A, DTPw-HBV/Hib and OPV or IPV in children who completed the primary vaccination course in study 107007 Study Listed on ClinicalStudyDataRequest.com
109563 Completed COMPAS: A phase III study to demonstrate efficacy of GSK Biologicals' 10-valent pneumococcal vaccine (GSK1024850A) against Community Acquired Pneumonia and Acute Otitis Media Study Listed on ClinicalStudyDataRequest.com
109609 Terminated A Phase II, Non-randomized, Multi-center Study to Evaluate the Efficacy and Safety of Pazopanib (GW786034) in Subjects with Advanced Non-Small Cell Lung Cancer
109616 (Y7) Completed Follow-up study to evaluate the long-term efficacy of a HPV vaccine (580299) in healthy young adult women in Brazil Study Listed on ClinicalStudyDataRequest.com
109616 (Y7) Completed Follow-up study to evaluate the long-term efficacy of a HPV vaccine (580299) in healthy young adult women in Brazil Study Listed on ClinicalStudyDataRequest.com
109621 Completed Safety, reactogenicity and immunogenicity following booster dose of GSK Biologicals´ pneumococcal conjugate vaccine when co-administered with a booster dose of Infanrix-IPV/Hib in preterm born children at 16-18 months of age Study Listed on ClinicalStudyDataRequest.com
109628 Completed Safety and immunogenicity study of an additional dose of HPV vaccine (580299) in young, adult women in North America. Study Listed on ClinicalStudyDataRequest.com
109630 Completed Assess the consistency of the immunogenicity of a GlaxoSmithKline Biologicals' pandemic influenza vaccine (GSK1562902A) in adults aged between 18 and 60 years Study Listed on ClinicalStudyDataRequest.com
109652 Completed A single-centre open label study to investigate the effect of repeat doses of SB-649868 on the pharmacokinetics of Simvastatin and Atorvastatin in healthy male volunteers. Study Listed on ClinicalStudyDataRequest.com
109661 Completed Primary vaccination course in children receiving the pneumococcal vaccine GSK 1024850A, Infanrix hexa and Rotarix Study Listed on ClinicalStudyDataRequest.com
109664 Completed Assessment of long-term antibody persistence after a booster dose of GSK Biologicals’ Hib & meningococcal C vaccine (Menitorix™) 811936 given at 12-15 months of age to subjects primed with 3 doses of Menitorix™ at 2, 3, 4 months of age Study Listed on ClinicalStudyDataRequest.com

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.